A2487612
Carmustine , ≥98% , 154-93-8
Synonym(s):
1,3-Bis(2-chloroethyl)-1-nitrosourea;BCNU
CAS NO.:154-93-8
Empirical Formula: C5H9Cl2N3O2
Molecular Weight: 214.05
MDL number: MFCD00057706
EINECS: 205-838-2
Pack Size | Price | Stock | Quantity |
25MG | RMB39.20 | In Stock |
|
100MG | RMB71.20 | In Stock |
|
500MG | RMB213.60 | In Stock |
|
1g | RMB245.60 | In Stock |
|
5g | RMB693.60 | In Stock |
|
25G | RMB1885.60 | In Stock |
|
others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 30 °C (lit.) |
Density | 1.6948 (rough estimate) |
refractive index | 1.6100 (estimate) |
storage temp. | -20°C |
solubility | insoluble in H2O; ≥21.51 mg/mL in DMSO; ≥27.15 mg/mL in EtOH |
form | (Oily liquid to amorphous solid) |
pka | 10.19±0.46(Predicted) |
color | Light-yellow powder |
Water Solubility | <0.1 g/100 mL at 18 ºC |
Merck | 14,1845 |
Stability: | Temperature Sensitive |
InChIKey | DLGOEMSEDOSKAD-UHFFFAOYSA-N |
Description and Uses
Carmustine is a nitrogen mustard β-chloro-nitrosourea compound that is used as an alkylating agent. It forms interstrand crosslinks in DNA, which prevents DNA replication and transcription leading to apoptosis. Carmustine is also reported to inhibit glutathione reductase, thioredoxin reductase, and lipoamide dehydrogenase. Carmustine has been tested in clinical trials as a cytostatic agent for Hodgkin’s and non-Hodgkin’s lymphoma, myeloma, malignant melanoma, glioblastoma, and other brain tumors.
antidepressant
Safety
Symbol(GHS) | GHS06,GHS08 |
Signal word | Danger |
Hazard statements | H300-H350-H360 |
Precautionary statements | P201-P280-P301+P330+P331+P310-P308+P313 |
Hazard Codes | T+ |
Risk Statements | 45-46-60-61-28 |
Safety Statements | 53-22-36/37/39-45 |
RIDADR | 3249 |
WGK Germany | 3 |
RTECS | YS2625000 |
HazardClass | 6.1(a) |
PackingGroup | II |
HS Code | 29241990 |
Toxicity | LD50 in mice (mg/kg): 19-25 orally, 26 i.p., 24 s.c.; in rats (mg/kg): 30-34 orally (Thompson, Larson) |